PAI Pharma, Olympus Partners Acquire Nivagen to Expand US Sterile Injectable Manufacturing
Deal strengthens domestic pharmaceutical production with advanced aseptic facility and robust ready-to-use injectable pipeline.
Olympus Partners | 09/01/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy